Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.55
Bid: 9.30
Ask: 9.80
Change: -0.05 (-0.52%)
Spread: 0.50 (5.376%)
Open: 9.60
High: 9.60
Low: 9.55
Prev. Close: 9.60
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

15 Feb 2021 11:00

RNS Number : 1128P
Scancell Holdings Plc
15 February 2021
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEEAFASFEEFEFA

Date   Source Headline
18th Jan 20237:00 amRNSNotice of Interim Results
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20223:18 pmRNSResult of Annual General Meeting
7th Nov 20227:00 amRNSLicenses Vaccitech technology to advance Modi-2
31st Oct 20227:00 amRNSFirst patient dosed in expansion phase of ModiFY
28th Oct 20223:00 pmRNSNotice of AGM
28th Oct 20227:00 amRNSResults for the year ended 30 April 2022
26th Oct 20227:00 amRNSDirectorate Changes
25th Oct 20224:42 pmRNSSecond Price Monitoring Extn
25th Oct 20224:37 pmRNSPrice Monitoring Extension
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 202211:05 amRNSSecond Price Monitoring Extn
25th Oct 202211:00 amRNSPrice Monitoring Extension
25th Oct 20227:00 amRNSSigns Commercial License Agreement with Genmab
13th Oct 20227:00 amRNSChange of Nominated Adviser
28th Sep 202212:31 pmRNSHolding(s) in Company
23rd Sep 20227:00 amRNSPreclinical data at the EuroMAbNet Annual Meeting
23rd Sep 20227:00 amRNSPreclinical data at the EuroMAbNet Annual Meeting
6th Sep 202212:54 pmRNSChange of Registered Office
16th Aug 20222:00 pmRNSFirst patient dosed in Cohort 2 of the ModiFY
23rd Jun 20227:00 amRNSScancell to produce TCB antibodies
15th Jun 20222:06 pmRNSSecond Price Monitoring Extn
15th Jun 20222:00 pmRNSPrice Monitoring Extension
15th Jun 20227:00 amRNSPhase 2 SCOPE trial of SCIB1 vaccine expanded
13th Jun 20227:00 amRNSFirst patient dosed in Modi-1 Phase 1 trial
12th Apr 20223:47 pmRNSChange of Registered Holder of Shares
11th Apr 20222:06 pmRNSSecond Price Monitoring Extn
11th Apr 20222:00 pmRNSPrice Monitoring Extension
11th Apr 202211:05 amRNSSecond Price Monitoring Extn
11th Apr 202211:00 amRNSPrice Monitoring Extension
11th Apr 20227:00 amRNSModi-1 Phase 1/2 trial open for recruitment
29th Mar 20227:00 amRNSUpdate on COVIDITY clinical trial
17th Mar 20227:00 amRNSScancell progresses its new anti-glycan mAb
3rd Mar 20229:55 amRNSDirector Dealing
31st Jan 20227:00 amRNSUpdate on COVIDITY Phase 1 clinical trial
26th Jan 20227:00 amRNSInterim Results for the 6 months ended 31 Oct 2021
22nd Dec 20219:45 amRNSNotice of Interim Results
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20213:58 pmRNSResult of AGM
19th Nov 20217:00 amRNSFirst patient dosed in SCIB1 Phase 2 trial
3rd Nov 202110:28 amRNSDirector Dealing
2nd Nov 202110:07 amRNSDirector Dealing
1st Nov 20219:50 amRNSNotice of Annual General Meeting
29th Oct 20217:00 amRNSResults for the year ended 30 April 2021
28th Oct 202111:23 amRNSExtension of CLN Redemption Dates
19th Oct 20217:00 amRNSNew facilities at The Oxford Science Park
15th Oct 20217:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.